DIVI - ETF AI Analysis
Top Page
Franklin LibertyQ International Equity Hedged ETF (DIVI)
DIVI, the Franklin LibertyQ International Equity Hedged ETF, earns a solid overall rating largely because it holds several financially strong global leaders like HSBC, AstraZeneca, Novartis, ASML, and Siemens, which bring robust profits, reasonable valuations, and generally supportive technical trends. Some holdings, such as BHP and Roche, introduce short-term momentum or valuation concerns that slightly weigh on the fund, and the presence of multiple large pharmaceutical and financial names means investors should be aware of sector concentration risk.
DIVI vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.63B
- Region
- Developed Markets
- Expense Ratio
- 0.09%
- Beta
- 0.73
- Issuer
- Franklin
- Inception Date
- Jun 01, 2016
- Dividend Yield
- 3.69%
- Asset Class
- Equity
- Index Tracked
- Morningstar Developed Markets ex-North America Dividend Enhanced Select
DIVI Summary
Franklin LibertyQ International Equity Hedged ETF (DIVI) is an exchange-traded fund that follows the Morningstar Developed Markets ex-North America Dividend Enhanced Select Index. It invests in international companies that pay relatively high dividends, aiming to give investors steady income plus global diversification while reducing currency swings. The fund holds well-known names like Nestlé, Toyota, ASML, HSBC, and AstraZeneca across many countries and sectors. Someone might invest in DIVI to add overseas dividend income to their portfolio without taking on full currency risk. A key risk is that the share price and dividend payments can still go up and down with global stock markets.
How much will it cost me?
The Franklin LibertyQ International Equity Hedged ETF (DIVI) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on tracking an index rather than active stock selection.
What would affect this ETF?
The Franklin LibertyQ International Equity Hedged ETF (DIVI) could benefit from stable or growing dividend payouts in developed markets outside North America, particularly in sectors like financials and technology, which are its largest exposures. However, economic slowdowns or regulatory changes in these regions, as well as sector-specific challenges like reduced demand in industrials or healthcare, could negatively impact performance. Additionally, while currency hedging reduces volatility, unexpected shifts in global trade policies or geopolitical tensions might still affect the ETF's returns.
DIVI Top 10 Holdings
DIVI leans heavily on a mix of European financials and global blue chips, with ASML and BHP acting as key engines of performance thanks to their rising longer-term trends, even if near-term trading has been a bit choppy. Big banks like HSBC, Mitsubishi UFJ, and Intesa Sanpaolo are generally steady to rising, giving the fund a solid income-focused backbone. On the defensive side, Nestlé and AstraZeneca have been lagging, slightly dulling the fund’s shine. Overall, it’s a developed-markets ex-North America play, anchored in Europe and Asia with a dividend tilt.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 2.98% | $79.13M | EUR 570.61B | 67.88% | 76Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 GB:HSBA | HSBC Holdings | 1.42% | $37.71M | GBP 237.35B | 41.99% | 80Outperform |
 CH:NESN | Nestlé SA | 1.38% | $36.61M | CHF 213.78B | 1.09% | 71Outperform |
 CH:NOVN | Novartis AG | 1.21% | $32.07M | CHF 232.26B | 21.35% | 80Outperform |
 DE:SIE | Siemens | 1.16% | $30.68M | EUR 198.38B | 10.27% | 74Outperform |
 AU:BHP | BHP Group Ltd | 1.11% | $29.51M | AUD 302.47B | 32.65% | 68Neutral |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 DE:SAP | SAP SE | 1.10% | $29.09M | EUR 235.32B | -13.21% | 66Neutral |
 GB:BATS | British American Tobacco | 1.03% | $27.38M | GBP 94.31B | 17.52% | 71Outperform |
DIVI Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVI, the sentiment is Positive. The current price of 42.68 is above the 20-day moving average (MA) of 42.56, below the 50-day MA of 43.40, and above the 200-day MA of 41.77, indicating a neutral trend. The MACD of -0.24 indicates Negative momentum. The RSI at 48.69 is Neutral, neither overbought nor oversold. The STOCH value of 56.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVI.
DIVI Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DIVI | $42.68 | $47.00(10.12% Upside) | $2.63B | 0.09% | 66Neutral |
 IDV | $42.57 | $48.54(14.03% Upside) | $8.31B | 0.50% | 59Neutral |
 HDEF | $33.92 | $36.40(7.30% Upside) | $2.33B | 0.09% | 67Neutral |
 FGD | $33.36 | $36.67(9.91% Upside) | $1.58B | 0.55% | 58Neutral |
 DTH | $55.93 | $62.33(11.44% Upside) | $636.45M | 0.58% | 61Neutral |
 EFAS | $22.11 | $24.69(11.66% Upside) | $60.60M | 0.55% | 56Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DIVI | Franklin LibertyQ International Equity Hedged ETF | 42.68 | 6.15 | 16.83% | |
| IDV | iShares International Select Dividend ETF | 42.57 | 7.47 | 21.26% | |
| HDEF | Xtrackers MSCI EAFE High Dividend Yield Equity ETF | 33.92 | 5.18 | 18.01% | |
| FGD | First Trust Dow Jones Global Select Dividend Index Fund | 33.36 | 5.95 | 21.71% | |
| DTH | WisdomTree International High Dividend Fund | 55.93 | 8.84 | 18.76% | |
| EFAS | Global X MSCI SuperDividend EAFE ETF | 22.11 | 4.39 | 24.75% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.